Stocktoria
PULSE BIOSCIENCES, INC. PLSE
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-05-18
Chart by TradingView
2/9
Piotroski F — financial health
-10.11
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $350,000 | $0 | $0 | $700,000 | $1.4M |
| Operating income | -$76.9M | -$56.3M | -$43.6M | -$58.1M | -$63.0M |
| Net income | -$72.8M | -$53.6M | -$42.2M | -$58.5M | -$63.7M |
| Operating cash flow | -$54.1M | -$36.3M | -$33.0M | -$47.0M | -$54.1M |
| Free cash flow | -$54.4M | -$36.5M | -$33.2M | -$47.4M | -$54.5M |
| Total assets | $94.5M | $132.5M | $59.2M | $77.9M | $59.2M |
| Total liabilities | $13.9M | $17.6M | $14.8M | $80.1M | $14.8M |
| Shareholders' equity | $80.7M | $114.9M | $44.4M | -$2.2M | $44.4M |
| Ratios | |||||
| Operating margin | -21982.6% | — | — | -8293.9% | -4443.9% |
| Net margin | -20794.6% | — | — | -8357.9% | -4489.4% |
| FCF margin | -15553.4% | — | — | -6773.4% | -3845.8% |
| Return on assets | -77.0% | -40.5% | -71.4% | -75.1% | -107.6% |
| Return on equity | -90.2% | -46.7% | -95.2% | 2602.5% | -143.5% |
| Current ratio | 10.53 | 11.88 | 6.76 | 10.39 | 6.76 |
| Revenue growth | — | — | -100.0% | -50.6% | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -10.11 (distress)
- Working capital / assets 0.799
- Retained earnings / assets -4.9
- EBIT / assets -0.814
- Equity / liabilities 5.81
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001625101 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.